Hiroyuki Kitabatake

Suggest Changes
Learn More
AIM Non-invasive steatosis-quantifying methods are required for non-alcoholic fatty liver disease (NAFLD) patients in order to monitor disease severity and assess therapeutic efficacy. Controlled(More)
  • 1